Hepatitis A-typhoid vaccine - Sanofi
Alternative Names: HA/Vi; ViATIM; VivaximLatest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Class Bacterial vaccines; Hepatitis A vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hepatitis A; Typhoid
Most Recent Events
- 19 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 27 Aug 2004 Aventis has merged with Sanofi-Synthélabo to form Sanofi-Aventis
- 11 Mar 2003 Launched for Hepatitis A in European Union (Injection)